Acquisition and carriage of genetically diverse multi-drug resistant gram-negative bacilli in hospitalised newborns in The Gambia.


Journal

Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676

Informations de publication

Date de publication:
03 Jun 2023
Historique:
received: 05 12 2022
accepted: 25 05 2023
medline: 4 6 2023
pubmed: 4 6 2023
entrez: 3 6 2023
Statut: epublish

Résumé

This detailed genomic study characterised multi-drug resistant-Gram negative bacilli (MDR-GNB) carriage in neonates < 2 kg and paired mothers at a low-resource African hospital. This cross-sectional cohort study was conducted at the neonatal referral unit in The Gambia with weekly neonatal skin and peri-anal sampling and paired maternal recto-vaginal swabs. Prospective bacteriological culture used MacConkey agar with species identification by API20E and API20NE. All GNB isolates underwent whole genome sequencing on Illumina Miseq platform. Multi-Locus Sequence Typing and SNP-distance analysis identified strain type and relatedness. 135 swabs from 34 neonates and 21 paired mothers, yielded 137 GNB isolates, of which 112 are high quality de novo assemblies. Neonatal MDR-GNB carriage prevalence is 41% (14/34) at admission with 85% (11/13) new acquisition by 7d. Multiple MDR and ESBL-GNB species are carried at different timepoints, most frequently K. pneumoniae and E. coli, with heterogeneous strain diversity and no evidence of clonality. 111 distinct antibiotic resistance genes are mostly beta lactamases (Bla-AMPH, Bla-PBP, CTX-M-15, Bla-TEM-105). 76% (16/21) and 62% (13/21) of mothers have recto-vaginal carriage of ≥1 MDR-GNB and ESBL-GNB respectively, mostly MDR-E. coli (76%, 16/21) and MDR-K. pneumoniae (24%, 5/21). Of 21 newborn-mother dyads, only one have genetically identical isolates (E. coli ST131 and K. pneumoniae ST3476). Gambian hospitalised neonates exhibit high MDR and ESBL-GNB carriage prevalence with acquisition between birth and 7d with limited evidence supporting mother to neonate transmission. Genomic studies in similar settings are required to further understand transmission and inform targeted surveillance and infection prevention policies. Bacteria that are resistant to multiple antibiotics are an important cause of infection and death of newborns in low-resource countries, especially small or premature babies born in hospital settings. How these resistant bacteria are acquired on the skin and in the gut of newborns is not known, particularly whether they are commonly transferred from mothers. We studied the bacteria present in small Gambian newborns and their mothers to understand the type of bacteria, amount of antibiotic resistance, number of newborns and mothers affected and similarity of these bacteria between newborns and their mothers. We found that despite many newborns carrying these bacteria, they are different from those present in mothers. This suggests that the bacteria are acquired from the hospital environment. Our study highlights the importance of developing strategies to identify and reduce the presence of such bacteria in hospitals to reduce their acquisition by vulnerable hospitalised newborns.

Sections du résumé

BACKGROUND BACKGROUND
This detailed genomic study characterised multi-drug resistant-Gram negative bacilli (MDR-GNB) carriage in neonates < 2 kg and paired mothers at a low-resource African hospital.
METHODS METHODS
This cross-sectional cohort study was conducted at the neonatal referral unit in The Gambia with weekly neonatal skin and peri-anal sampling and paired maternal recto-vaginal swabs. Prospective bacteriological culture used MacConkey agar with species identification by API20E and API20NE. All GNB isolates underwent whole genome sequencing on Illumina Miseq platform. Multi-Locus Sequence Typing and SNP-distance analysis identified strain type and relatedness.
RESULTS RESULTS
135 swabs from 34 neonates and 21 paired mothers, yielded 137 GNB isolates, of which 112 are high quality de novo assemblies. Neonatal MDR-GNB carriage prevalence is 41% (14/34) at admission with 85% (11/13) new acquisition by 7d. Multiple MDR and ESBL-GNB species are carried at different timepoints, most frequently K. pneumoniae and E. coli, with heterogeneous strain diversity and no evidence of clonality. 111 distinct antibiotic resistance genes are mostly beta lactamases (Bla-AMPH, Bla-PBP, CTX-M-15, Bla-TEM-105). 76% (16/21) and 62% (13/21) of mothers have recto-vaginal carriage of ≥1 MDR-GNB and ESBL-GNB respectively, mostly MDR-E. coli (76%, 16/21) and MDR-K. pneumoniae (24%, 5/21). Of 21 newborn-mother dyads, only one have genetically identical isolates (E. coli ST131 and K. pneumoniae ST3476).
CONCLUSIONS CONCLUSIONS
Gambian hospitalised neonates exhibit high MDR and ESBL-GNB carriage prevalence with acquisition between birth and 7d with limited evidence supporting mother to neonate transmission. Genomic studies in similar settings are required to further understand transmission and inform targeted surveillance and infection prevention policies.
Bacteria that are resistant to multiple antibiotics are an important cause of infection and death of newborns in low-resource countries, especially small or premature babies born in hospital settings. How these resistant bacteria are acquired on the skin and in the gut of newborns is not known, particularly whether they are commonly transferred from mothers. We studied the bacteria present in small Gambian newborns and their mothers to understand the type of bacteria, amount of antibiotic resistance, number of newborns and mothers affected and similarity of these bacteria between newborns and their mothers. We found that despite many newborns carrying these bacteria, they are different from those present in mothers. This suggests that the bacteria are acquired from the hospital environment. Our study highlights the importance of developing strategies to identify and reduce the presence of such bacteria in hospitals to reduce their acquisition by vulnerable hospitalised newborns.

Autres résumés

Type: plain-language-summary (eng)
Bacteria that are resistant to multiple antibiotics are an important cause of infection and death of newborns in low-resource countries, especially small or premature babies born in hospital settings. How these resistant bacteria are acquired on the skin and in the gut of newborns is not known, particularly whether they are commonly transferred from mothers. We studied the bacteria present in small Gambian newborns and their mothers to understand the type of bacteria, amount of antibiotic resistance, number of newborns and mothers affected and similarity of these bacteria between newborns and their mothers. We found that despite many newborns carrying these bacteria, they are different from those present in mothers. This suggests that the bacteria are acquired from the hospital environment. Our study highlights the importance of developing strategies to identify and reduce the presence of such bacteria in hospitals to reduce their acquisition by vulnerable hospitalised newborns.

Identifiants

pubmed: 37270610
doi: 10.1038/s43856-023-00309-6
pii: 10.1038/s43856-023-00309-6
pmc: PMC10239441
doi:

Types de publication

Journal Article

Langues

eng

Pagination

79

Subventions

Organisme : Wellcome Trust (Wellcome)
ID : 200116/Z/15/Z

Informations de copyright

© 2023. The Author(s).

Références

Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Arch Dis Child. 2020 Jan;105(1):26-31
pubmed: 31446393
J Intensive Care. 2020 Jan 28;8:13
pubmed: 32015881
J Hosp Infect. 2005 Sep;61(1):68-74
pubmed: 15953660
BMC Infect Dis. 2006 Aug 16;6:130
pubmed: 16914034
Bioinformatics. 2013 Apr 15;29(8):1072-5
pubmed: 23422339
Am J Trop Med Hyg. 2019 Jun;100(6):1355-1362
pubmed: 31017082
Trials. 2020 Mar 6;21(1):247
pubmed: 32143737
Front Cell Infect Microbiol. 2022 Aug 25;12:892126
pubmed: 36093198
J Hosp Infect. 1999 Dec;43(4):299-304
pubmed: 10658806
Paediatr Int Child Health. 2015 Aug;35(3):265-72
pubmed: 25940506
Clin Microbiol Infect. 2018 Mar;24(3):251-257
pubmed: 28830807
J Pediatr. 1991 Sep;119(3):417-23
pubmed: 1880657
J Glob Antimicrob Resist. 2017 Mar;8:90-96
pubmed: 28039104
Clin Infect Dis. 2015 May 1;60(9):1389-97
pubmed: 25595742
J Pediatric Infect Dis Soc. 2015 Mar;4(1):11-20
pubmed: 26407352
Clin Microbiol Infect. 2023 Mar;29(3):386.e1-386.e9
pubmed: 36243352
J Clin Microbiol. 2015 Jul;53(7):2122-31
pubmed: 25903575
Infect Control Hosp Epidemiol. 1999 Apr;20(4):233-6
pubmed: 10219872
Lancet Microbe. 2020 Jul;1(3):e119-e129
pubmed: 35544262
Bioinformatics. 2015 Nov 15;31(22):3691-3
pubmed: 26198102
J Investig Med. 2011 Dec;59(8):1284-6
pubmed: 22068018
J Clin Microbiol. 2013 Oct;51(10):3421-2
pubmed: 23926162
Int J Infect Dis. 2017 Apr;57:79-85
pubmed: 28161461
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Paediatr Int Child Health. 2015 Aug;35(3):252-64
pubmed: 26052891
Lancet Glob Health. 2019 Jan;7(1):e37-e46
pubmed: 30389451
Microorganisms. 2021 Feb 27;9(3):
pubmed: 33673648
Open Forum Infect Dis. 2020 Mar 28;7(4):ofaa109
pubmed: 32373647
Nucleic Acids Res. 2017 Jan 4;45(D1):D574-D580
pubmed: 27899569
JAC Antimicrob Resist. 2021 Jul 12;3(3):dlab087
pubmed: 34263166
BMC Infect Dis. 2018 Jul 28;18(1):351
pubmed: 30055584
Am J Trop Med Hyg. 2013 Nov;89(5):960-964
pubmed: 24043693
Pediatr Infect Dis J. 2002 Nov;21(11):1029-33
pubmed: 12442024
Lancet Infect Dis. 2019 Nov;19(11):1219-1234
pubmed: 31522858
Infect Control Hosp Epidemiol. 2000 May;21(5):305-7; author reply 307-8
pubmed: 10823560
J Hosp Infect. 2020 Jan;104(1):57-67
pubmed: 31604126
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Lancet. 2014 Aug 2;384(9941):455-67
pubmed: 24853599
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Clin Microbiol Infect. 1997 Jun;3(3):324-328
pubmed: 11864128
Bull World Health Organ. 2015 Jan 1;93(1):19-28
pubmed: 25558104
PLoS Negl Trop Dis. 2019 Oct 14;13(10):e0007801
pubmed: 31609963
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Resist Infect Control. 2016 May 14;5:18
pubmed: 27186369
Curr Opin Microbiol. 2020 Aug;56:30-37
pubmed: 32634598
Lancet. 2016 Jan 9;387(10014):168-75
pubmed: 26603918
Front Microbiol. 2016 Sep 05;7:1374
pubmed: 27656166
BMC Infect Dis. 2010 Jul 12;10:204
pubmed: 20624313
PLoS One. 2012;7(12):e51981
pubmed: 23284838
Scand J Infect Dis. 2013 Jan;45(1):54-8
pubmed: 22991960
Antimicrob Agents Chemother. 2010 Mar;54(3):969-76
pubmed: 19995920
Nat Microbiol. 2021 Apr;6(4):512-523
pubmed: 33782558
J Matern Fetal Neonatal Med. 2018 May;31(9):1227-1233
pubmed: 28423971
BMC Health Serv Res. 2018 Jun 18;18(1):465
pubmed: 29914477
Int J Antimicrob Agents. 2017 Nov;50(5):622-628
pubmed: 28733213
Elife. 2019 Dec 03;8:
pubmed: 31793878
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
PLoS One. 2018 Mar 1;13(3):e0193325
pubmed: 29494706
Emerg Infect Dis. 2018 Apr;24(4):710-717
pubmed: 29553312

Auteurs

Saikou Y Bah (SY)

The Florey Institute of Host-Pathogen Interactions, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Mariama A Kujabi (MA)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Saffiatou Darboe (S)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Ngange Kebbeh (N)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Bunja F K Kebbeh (BFK)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Abdoulie Kanteh (A)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Ramatouille Bojang (R)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Joy E Lawn (JE)

Department of Infectious Disease Epidemiology, Faculty of Epidemiology & Population Health London School of Hygiene & Tropical Medicine, London, UK.

Beate Kampmann (B)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.
Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
Institut fur Internationale Gesundheit and Centre for Global Health, Charite Universitatsmedizin, Berlin, Germany.

Abdul K Sesay (AK)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Thushan I de Silva (TI)

The Florey Institute of Host-Pathogen Interactions, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia.

Helen Brotherton (H)

MRC Unit, The Gambia at LSHTM, Atlantic Road, Fajara, The Gambia. helen.brotherton@lshtm.ac.uk.
Department of Infectious Disease Epidemiology, Faculty of Epidemiology & Population Health London School of Hygiene & Tropical Medicine, London, UK. helen.brotherton@lshtm.ac.uk.

Classifications MeSH